Compare Stocks

Date Range: 

 Orphazyme A/SORIC PharmaceuticalsChimerixCalliditas Therapeutics AB (publ)Sesen Bio
SymbolNASDAQ:ORPHNASDAQ:ORICNASDAQ:CMRXNASDAQ:CALTNASDAQ:SESN
Price Information
Current Price$6.52$18.90$8.20$28.00$4.17
52 Week RangeSellBuyBuyBuyBuy
MarketRank™
Overall Score0.81.61.71.31.3
Analysis Score2.73.34.53.53.5
Community Score1.42.92.42.62.6
Dividend Score0.00.00.00.00.0
Ownership Score0.01.70.80.00.0
Earnings & Valuation Score0.00.00.60.60.6
Analyst Ratings
Consensus RecommendationSellBuyBuyBuyBuy
Consensus Price Target$16.00$44.33$19.00$40.80$7.50
% Upside from Price Target145.40% upside134.57% upside131.71% upside45.71% upside79.86% upside
Trade Information
Market Cap$227.89 million$693.55 million$706.93 million$699.19 million$722.61 million
BetaN/A2.811.59N/A0.82
Average Volume3,966,042244,033983,46633,4556,522,474
Sales & Book Value
Annual RevenueN/AN/A$5.37 million$90,000.00$11.24 million
Price / SalesN/AN/A131.647,768.7664.29
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.74 per share$9.40 per share$1.17 per share$5.71 per share($0.07) per share
Price / BookN/AN/A7.014.90-59.57
Profitability
Net Income$-97,010,000.00$-73,700,000.00$-43,520,000.00$-47,250,000.00$-22,400,000.00
EPS($3.42)($3.36)($0.70)($2.11)($0.15)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A29.79
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-2,344.90%N/AN/A
Return on Equity (ROE)N/A-34.41%-49.70%-39.44%N/A
Return on Assets (ROA)N/A-33.33%-43.44%-35.09%-87.65%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/AN/AN/AN/A
Current Ratio4.70%36.49%6.66%7.75%7.29%
Quick Ratio4.70%36.49%6.66%7.75%7.29%
Ownership Information
Institutional Ownership Percentage0.83%97.25%55.88%9.35%23.14%
Insider Ownership PercentageN/AN/A9.00%N/A2.20%
Miscellaneous
Employees14161543427
Shares Outstanding34.95 million36.70 million86.21 million24.97 million173.29 million
Next Earnings DateN/A8/4/2021 (Estimated)8/9/2021 (Estimated)8/12/2021 (Estimated)8/9/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable
SourceHeadline
Should This Make Sesen Bio Inc. (NASDAQ: SESN) Investors Sleepless At Night?Should This Make Sesen Bio Inc. (NASDAQ: SESN) Investors Sleepless At Night?
stocksregister.com - June 21 at 8:45 AM
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MorningstarSesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Morningstar
morningstar.com - June 20 at 12:43 AM
Sesen Bio, Inc. (NASDAQ:SESN) Has Recovered 85.29% So Far, But Another 4% Gain Cannot Be Ruled OutSesen Bio, Inc. (NASDAQ:SESN) Has Recovered 85.29% So Far, But Another 4% Gain Cannot Be Ruled Out
marketingsentinel.com - June 18 at 12:57 PM
Sesen Bio (NASDAQ:SESN) Trading Up 8.5%Sesen Bio (NASDAQ:SESN) Trading Up 8.5%
americanbankingnews.com - June 17 at 12:19 PM
A Look At Sesen Bio Inc. (SESN) Stock PerformanceA Look At Sesen Bio Inc. (SESN) Stock Performance
stocksregister.com - June 17 at 10:04 AM
Sesen Bio Inc. [SESN] Revenue clocked in at $15.50 million, up 211.11% YTD: What’s Next?Sesen Bio Inc. [SESN] Revenue clocked in at $15.50 million, up 211.11% YTD: What’s Next?
dbtnews.com - June 16 at 6:16 PM
Sesen Bio (NASDAQ:SESN) Is In A Strong Position To Grow Its BusinessSesen Bio (NASDAQ:SESN) Is In A Strong Position To Grow Its Business
finance.yahoo.com - June 15 at 2:49 PM
Sesen Bio Inc. (SESN) Has Great Growth Outlook For 2021Sesen Bio Inc. (SESN) Has Great Growth Outlook For 2021
marketingsentinel.com - June 15 at 9:25 AM
Sesen Bio (NASDAQ:SESN) Reaches New 12-Month High at $4.36Sesen Bio (NASDAQ:SESN) Reaches New 12-Month High at $4.36
americanbankingnews.com - June 14 at 11:02 AM
Is Now The Right Time To Buy Sesen Bio Inc. (NASDAQ: SESN) Stock?Is Now The Right Time To Buy Sesen Bio Inc. (NASDAQ: SESN) Stock?
stocksregister.com - June 14 at 8:45 AM
Sesen Bio Inc. (NASDAQ: SESN) Continues To Thrive In 2021, As Its Stock Is Up 209.63% Year-To-DateSesen Bio Inc. (NASDAQ: SESN) Continues To Thrive In 2021, As Its Stock Is Up 209.63% Year-To-Date
marketingsentinel.com - June 11 at 7:31 AM
Sesen Bio Inc. (NASDAQ: SESN)’s Upside Potential Is HighSesen Bio Inc. (NASDAQ: SESN)’s Upside Potential Is High
stocksregister.com - June 10 at 9:52 AM
Sesen Bio (NASDAQ:SESN) Reaches New 52-Week High at $3.97Sesen Bio (NASDAQ:SESN) Reaches New 52-Week High at $3.97
americanbankingnews.com - June 7 at 1:20 PM
Sesen Bio, Inc. (NASDAQ:SESN)’s stock boosts 1.35%, but it may be a worthy investmentSesen Bio, Inc. (NASDAQ:SESN)’s stock boosts 1.35%, but it may be a worthy investment
stocksregister.com - June 7 at 12:21 PM
Sesen Bio, Inc. (NASDAQ:SESN) Have Surged 174.07% YTD, Predicting what happens next inSesen Bio, Inc. (NASDAQ:SESN) Have Surged 174.07% YTD, Predicting what happens next in
marketingsentinel.com - June 4 at 1:58 PM
Analysts Recommend Holding Your Position In Sesen Bio Inc. (NASDAQ: SESN)Analysts Recommend Holding Your Position In Sesen Bio Inc. (NASDAQ: SESN)
stocksregister.com - June 2 at 12:59 PM
Sesen Bio (NASDAQ:SESN) Shares Gap Down to $3.87Sesen Bio (NASDAQ:SESN) Shares Gap Down to $3.87
americanbankingnews.com - June 2 at 10:55 AM
Sesen Bio, Inc. (NASDAQ:SESN) Stock Forecast for 2021: Bullish Signs Point to $8 per ShareSesen Bio, Inc. (NASDAQ:SESN) Stock Forecast for 2021: Bullish Signs Point to $8 per Share
marketingsentinel.com - June 1 at 2:09 PM
Sesen Bio (NASDAQ:SESN) Reaches New 1-Year High at $3.60Sesen Bio (NASDAQ:SESN) Reaches New 1-Year High at $3.60
americanbankingnews.com - June 1 at 1:40 PM
Sesen Bio Strengthens Senior Leadership TeamSesen Bio Strengthens Senior Leadership Team
finance.yahoo.com - June 1 at 8:18 AM
Market Analysts see Sesen Bio Inc. [SESN] gaining to $3. Time to buy?Market Analysts see Sesen Bio Inc. [SESN] gaining to $3. Time to buy?
dbtnews.com - May 31 at 2:05 PM
Sesen Bio, Inc. (NASDAQ:SESN) Sees Significant Growth in Short InterestSesen Bio, Inc. (NASDAQ:SESN) Sees Significant Growth in Short Interest
americanbankingnews.com - May 30 at 3:40 AM
Sesen Bio (NASDAQ:SESN) Sees Unusually-High Trading VolumeSesen Bio (NASDAQ:SESN) Sees Unusually-High Trading Volume
americanbankingnews.com - May 28 at 10:50 AM
Sesen Bio, Inc. (NASDAQ:SESN) Stock You Missed During the WeekSesen Bio, Inc. (NASDAQ:SESN) Stock You Missed During the Week
stocksregister.com - May 27 at 5:29 PM
Sesen Bio, Inc. (NASDAQ:SESN) Has Recovered 77.56% So Far, But Another 21.02% Gain Cannot Be Ruled OutSesen Bio, Inc. (NASDAQ:SESN) Has Recovered 77.56% So Far, But Another 21.02% Gain Cannot Be Ruled Out
marketingsentinel.com - May 27 at 12:29 PM
DateCompanyBrokerageAction
6/21/2021Orphazyme A/SGuggenheimDowngrade
6/18/2021Orphazyme A/SCowenDowngrade
3/30/2021Orphazyme A/SBank of AmericaDowngrade
6/6/2021ORIC PharmaceuticalsRobert W. BairdReiterated Rating
3/25/2021ORIC PharmaceuticalsHC WainwrightBoost Price Target
1/25/2021ORIC PharmaceuticalsCitigroupDowngrade
6/19/2020ORIC PharmaceuticalsOppenheimerReiterated Rating
5/19/2020ORIC PharmaceuticalsJPMorgan Chase & Co.Initiated Coverage
5/19/2020ORIC PharmaceuticalsJefferies Financial GroupInitiated Coverage
4/29/2021ChimerixMaxim GroupInitiated Coverage
4/12/2021ChimerixJonestradingReiterated Rating
3/31/2021ChimerixWedbushInitiated Coverage
8/18/2020Calliditas Therapeutics AB (publ)Ci CapitalReiterated Rating
6/30/2020Calliditas Therapeutics AB (publ)Stifel NicolausInitiated Coverage
3/16/2021Sesen BioCanaccord GenuityReiterated Rating
8/9/2019Sesen BioLaidlawDowngrade
(Data available from 6/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.